Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Global Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of respiratory and cardiovascular medications. A key subsidiary of China Grand Pharmaceutical and Healthcare Holdings, the company is well-known for its production of anti-allergic and anti-asthmatic drugs, including the widely used Loratadine and Budesonide formulations. The company operates large-scale manufacturing facilities that comply with national GMP standards, focusing on both finished dosage forms and active pharmaceutical ingredients. Its product portfolio serves a significant portion of the domestic Chinese market, particularly in the treatment of chronic respiratory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Global Pharmaceutical.